Mercer University and Navicent Health (https://www.navicenthealth.org/) conduct collaborative medical research to serve the residents of Central Georgia. Mercer University, through its School of Medicine, and Navicent Health have collectively agreed to participate in clinical trials combining the University's academic support with Navicent's hospital facilities and patients to improve the quality of patient care. For more information on Navicent Health Clinical Trials, visit the Navicent Health Clinical Trial Home Page.
To help achieve this goal, Mercer University's Institutional Review Board for Human Subject Research (IRB) has designated Navicent's IRB to review research protocols that involve study subjects who are patients at Navicent. As a designated IRB, Navicent will meet the requirements of Mercer University's Federal Wide Assurance (FWA) for human subject protections with the Office of Human Research Protections (OHRP) at the Department of Health and Human Services (DHHS). The IRB at Navicent will follow written procedures for reporting its findings and actions to Mercer University's IRB. Mercer University will remain responsible for ensuring compliance with Navicent's IRB determinations and with the terms of the University's OHRP-approved FWA.
Mercer University's FWA-00000133 Mercer FWA – Search by “Mercer U"
Navicent Health Collaborative Research
An Memorandum of Understanding (MOU) exists between Navicent Health and Mercer University. The institution of primary employment of the Lead Principal Investigator or the institution where most of the research is taking place will be the IRB of record. The appropriate departmental officials at both institutions must approve and sign the protocol application.
Student investigators cannot act as Principal Investigators for a Navicent Health Joint Protocol Research Study unless Mercer University is the IRB of record.
Mercer University faculty, staff, or students who wish to conduct research with Navicent will need to complete the joint application form. The Office of Research Compliance will forward the application to Navicent. Once the application is approved by Navicent’s IRB, human subject research can begin.
- Joint Protocol Application (Microsoft Word)
Additional forms for protocol modifications or continuing review are available through Navicent’s IRB Clinical Trial Forms
Submit all completed forms to:
Ava Chambliss-Richardson, Ph.D., CIP, CIM
Director of Research Compliance
Phone: (478) 301-4101
Fax: (478) 301-2329
For meeting dates and submission deadlines, view the Navicent IRB Meeting Schedule
Navicent Health Contact Person
777 Hemlock Street – MSC 113
Macon, GA 31201-2102
Phone: (478) 633-1440